|
Initiation of Coverage: Biotest AG 04. November 2008  Sound prospects supported by bid speculation Biotest’s main business is developing blood plasma protein products. The group is the world’s sixth largest supplier of plasma proteins for use in haematology and immunology treatment. The group also develops compounds of monoclonal antibodies for the treatment of... ...Subscribe to VISCARDI Research... |
